Abstract:Background: Lophine is one of the new core moiety with the substitution of three phenyl rings at the 2nd, 4th, and 5th position of the imidazole. Lophine is not explored in the development of drug molecules. In this research, we have designed 30 lophine derivatives with different substituted functional groups. The designed compounds were evaluated through different in-silico tools and software to check their properties for different biological receptors. Methods: A molecular docking study was carried out on different receptors i.e. EGFR for anti-cancer, COX-1, and COX-2 for anti-inflammatory, fungal oxidoreductase for anti-fungal, bacterial DNA gyrase for anti-bacterial and TNF-α, which co-relates different type of inflammatory diseases. Further, ADMET of the top docked compounds were carried out in SwissADME and ProTox-II webserver. The MD simulation was carried out to check the stability of the compounds inside the binding pocket of the different proteins. Finally, the common pharmacophore was generated by the PharmaGist web server. Results: The molecular docking results revealed that the SAP-28 has significant binding energies -9.8, -9.6, and -10.0 kcal/mol against EGFR, fungal oxidoreductase, and TNF-α receptors respectively. SAP-26 has potent interaction -9.8 and -11.0 kcal/mol against EGFR and COX-2 receptors respectively. Whereas, SAP-25 and SAP-19 showed the best interaction for bacterial DNA gyrase (-8.9 kcal/mol) and COX-1 receptor (-9.7 kcal/mol) respectively. To enhance the acceptability top docked compounds, the ADME parameters along with toxicity analysis were carried out where all the compounds showed acceptable results. Furthermore, the stability of the protein-ligand complexes was determined by a 100 ns MD simulation analysis, and compounds were found stable. The common pharmacophore was generated with the help of the top compounds in the PharmaGist web server. Conclusion: This in-silico study established that, various substitutions on the phenyl ring present in the 2nd position of the imidazole such as 2-hydroxy, 2-methyl, 3-methyl, 4-pyridinyl, etc. governing their ability to interact with diverse targets. The compound can contribute a major role in the development of different leads in the future. result: The molecular docking results revealed that the SAP-28 has significant binding energies -9.8, -9.6 and -10.0 kcal/mol against EGFR, fungal oxidoreductase, and TNF-α receptors respectively. SAP-26 has potent interaction -9.8 and -11.0 kcal/mol against EGFR and COX-2 receptors respectively. Whereas, SAP-25 and SAP-19 showed the best interaction for bacterial DNA gyrase (-8.9 kcal/mol) and COX-1 receptor (-9.7 kcal/mol) respectively. To enhance the acceptability top docked compounds, the ADME parameters along with toxicity analysis were carried out where all the compounds showed acceptable results. Furthermore, the stability of the protein-ligand complexes were determined by a 100 ns MD simulation analysis. The common pharmacophore was generated with the help of the top compounds in the PharmaGist web server.

Structure-based De Novo Design, Synthesis, and Biological Evaluation of the Indole-Based PPARγ Ligands (I)

Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists

Design, Synthesis and Biological Evaluation of N,N-3-phenyl-3-benzylaminopropanamide Derivatives As Novel Cholesteryl Ester Transfer Protein Inhibitor

Design, Synthesis and Biological Evaluation of Novel Imidazolone Derivatives As Dipeptidyl Peptidase 4 Inhibitors.

Design, Synthesis and Biological Evaluation of Novel (Quinolinyl-3-pyridinyl)benzenesulfonamide-based Hydroxamic Acids As PI3K and HDAC Dual Targeting Inhibitors

Design, Synthesis and Computational Insight of Isolated and Thiophene fused 2H‐Pyran‐2‐ones as PPAR‐γ Agonist

Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)

Design, synthesis and biological evaluation of novel inosine 5′-monophosphate dehydrogenase (IMPDH) inhibitors

Design, synthesis and molecular docking studies of new indole scaffolds

Design, Synthesis and Evaluation of Indene Derivatives As Retinoic Acid Receptor Α Agonists

Molecular modeling studies of Indoline Scaffold derivatives as PD‐1/PD‐L1 pathway inhibitors by QSAR, molecular docking and molecular dynamics simulation techniques

Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARalpha selective activators.

Design, Synthesis and Biological Evaluation of Novel Indone Derivatives As Selective ERβ Modulators

Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2

Design, synthesis and biological evaluation of novel anticancer agent sprio indolone compounds

LigBuilder V3: A Multi-Target De Novo Drug Design Approach.

Prospective de novo drug design with deep interactome learning

Identification of a novel PPARγ modulator with good anti-diabetic therapeutic index via structure-based screening, optimization and biological validation

Reducing Without Side Effects? A Novel Strategy for Designing the Ppar Agonists

Design, synthesis and evaluation of 2-pyrimidinylindole derivatives as anti-obesity agents by regulating lipid metabolism

Design and Discovery of Lophine Derivatives as Multi-targeting Agents by Molecular Docking, ADMET, MD Simulation and Pharmacophore Analysis: A Computational Approach